tiprankstipranks
Trending News
More News >
Neurogene Reports Q1 2025 Financial Progress and Updates
PremiumCompany AnnouncementsNeurogene Reports Q1 2025 Financial Progress and Updates
28d ago
Optimistic Buy Rating for Neurogene Amid Favorable Market and Regulatory Conditions
Premium
Ratings
Optimistic Buy Rating for Neurogene Amid Favorable Market and Regulatory Conditions
29d ago
Promising Outlook for Neurogene’s NGN-401 Amid Favorable Regulatory Environment and Trial Precedents
Premium
Ratings
Promising Outlook for Neurogene’s NGN-401 Amid Favorable Regulatory Environment and Trial Precedents
30d ago
Neurogene downgraded to Neutral from Outperform at Baird
PremiumThe FlyNeurogene downgraded to Neutral from Outperform at Baird
1M ago
Neurogene price target lowered to $45 from $50 at H.C. Wainwright
Premium
The Fly
Neurogene price target lowered to $45 from $50 at H.C. Wainwright
2M ago
Neurogene’s Promising Outlook: Strategic Focus on Safety and Efficacy Justifies Buy Rating
Premium
Ratings
Neurogene’s Promising Outlook: Strategic Focus on Safety and Efficacy Justifies Buy Rating
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100